1-2 of 2
Nathan Roscoe
Close
Sort by
Journal Articles

Myc Expression and Tumor-Infiltrating T Cells Are Associated with Response in Patients (Pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Treated with Tisagenlecleucel in the Juliet Trial

Ulrich Jaeger, MD, Michael R. Bishop, MD, Gilles Salles, MDPhD, Stephen J. Schuster, MD, Richard T. Maziarz, MD, Xia Han, MS, Alexander Savchenko, MD, Nathan Roscoe, Mbt, Elena Orlando, PhD, Dawson Knoblock, PhD, Ranjan Tiwari, MSc, Lida Bubuteishvili Pacaud, MD, Paolo Corradini
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-137045
Published: 2020
Journal Articles

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Zijun Yidan Xu-Monette, PhD, Li Yu, MD, Thai Tran, Lisa Adams, Nathan Roscoe, Ganiraju Manyam, Carlo Visco, Alexandar Tzankov, Karen Dybkær, PhD, Govind Bhagat, MD, April Chiu, MD, Wayne Tam, MD PhD, Youli Zu, MD PhD, Eric D. Hsi, MD, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, MD PhD, Maurilio Ponzoni, MD, Andres Ferreri, MD, Michael Boe Møller, Miguel Angel Piris, PhDMD, Jane N. Winter, MD, L. Jeffrey Medeiros, MD, George Rassidakis, MD PhD, Christine Angela Vaupel, PhD, Yong Li, PhD, Naveen Dakappagari, Ken H. Young, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 197.
https://doi.org/10.1182/blood.V130.Suppl_1.197.197
Published: 2017